Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology - In Reply

被引:0
|
作者
Lordick, Florian [1 ]
Merz, Maximilian [2 ]
Aigner, Achim [3 ]
机构
[1] Univ klinikum Leipzig, Klin & Poliklin Onkol Gastroenterol Hepatol &, Mitteldeutsches Krebszentrum, Leipzig, Germany
[2] Univ klinikum Leipzig, Klin & Poliklin Hamatol Zelltherapie & Hamostase, Mitteldeutsches Krebszentrum, Leipzig, Germany
[3] Univ Leipzig, Rudolf Boehm Inst Pharmakol & Toxikol, Selbststandige Abt, Mitteldeutsches Krebszentrum,Klin Pharmakole,Med F, Leipzig, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2023年 / 120卷 / 38期
关键词
D O I
10.3238/arztebl.m2023.0168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:643 / 643
页数:1
相关论文
共 50 条
  • [1] Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology
    Lordick, Florian
    Merz, Maximilian
    Buech, Eva
    Aigner, Achim
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (19): : 329 - +
  • [2] Antibody-drug conjugates as new therapeutic agents in uro-oncology
    Grimm, Marc-Oliver
    Foller, Susan
    Leeder, Mirjam
    Leucht, Katharina
    UROLOGIE, 2023, 62 (07): : 679 - 684
  • [3] Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload
    Kondrashov, Aleksei
    Sapkota, Surendra
    Sharma, Aditya
    Riano, Ivy
    Kurzrock, Razelle
    Adashek, Jacob J.
    PHARMACEUTICS, 2023, 15 (08)
  • [4] Antibody-drug conjugates come of age in oncology
    Dumontet, Charles
    Reichert, Janice M. M.
    Senter, Peter D. D.
    Lambert, John M. M.
    Beck, Alain
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 641 - 661
  • [5] An FDA oncology analysis of antibody-drug conjugates
    Saber, Haleh
    Leighton, John K.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 71 (03) : 444 - 452
  • [6] Antibody-Drug Conjugates in Uro-Oncology
    Sigorski, Dawid
    Rozanowski, Pawel
    Izycka-Swieszewska, Ewa
    Wiktorska, Katarzyna
    TARGETED ONCOLOGY, 2022, 17 (03) : 203 - 221
  • [7] Optimizing the potential of antibody-drug conjugates in oncology
    Mosele, F.
    Montagnac, G.
    Pistilli, B.
    Andre, F.
    ANNALS OF ONCOLOGY, 2023, 34 (11) : 964 - 967
  • [8] Antibody-drug conjugates: targeted drug delivery for cancer
    Alley, Stephen C.
    Okeley, Nicole M.
    Senter, Peter D.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (04) : 529 - 537
  • [9] TARGETED DRUG DELIVERY AND ADME OF ANTIBODY-DRUG CONJUGATES
    Alley, Stephen C.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S9 - S9
  • [10] Antibody-Drug Conjugates for Targeted Cancer Therapy
    Goldmacher, Victor S.
    Chittenden, Thomas
    Chari, Ravi V. J.
    Kovtun, Yelena V.
    Lambert, John M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 349 - 366